Clinical Trials in Heze, Shandong
6 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 2
A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation Powder
Pulmonary Disease, Chronic Obstructive
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.195 enrolled29 locationsNCT07252908
Recruiting
Phase 2
A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease (COPD)
Mabwell (Shanghai) Bioscience Co., Ltd.360 enrolled51 locationsNCT07292714
Recruiting
Phase 1
A Clinical Study Assessing the Subcutaneous Formulation of TQB2934 for Injection in Subjects With Malignant Plasma Cell Tumors
Multiple Myeloma
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.42 enrolled14 locationsNCT07179679
Recruiting
Not Applicable
NWRD09 for HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer
Cervical CancerIntraepithelial Neoplasia
Newish Technology (Beijing) Co., Ltd.18 enrolled1 locationNCT07092007
Recruiting
Phase 3
TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection
Asthma
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.660 enrolled74 locationsNCT06829784
Recruiting
Phase 3
Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy.
Non-small Cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.518 enrolled71 locationsNCT05922345